Saturday, April 30, 2011

Minimising patent infringement risk before product launch

Managing risks in the pharma industry

Patients with asthma or allergies initially prescribed montelukast instead of typical first-line therapy have low rates of persistence on montelukast

Unigene completes patient enrolment in oral PTH phase II study to treat osteoporosis in postmenopausal women

US FDA approves Zytiga to treat metastatic prostate cancer

Pfizer announces top-line results of final two pivotal phase 3 trials of tofacitinib in patients with active RA

Friday, April 29, 2011

Aegerion gets patent for treating diseases associated with Hyperlipidemia & Hypercholesterolemia using lomitapide

Rwanda, Merck & Qiagen launch Africa’s first comprehensive cervical cancer prevention programme

BioAlliance Pharma accelerates its European clinical development of clonidine Lauriad

Call for Papers: International Conference on Nanotechnologies and Biomedical Engineering (ICNBME)

Call for Papers: International Conference on Nanotechnologies and Biomedical Engineering (ICNBME)

XIII Annual INFOTEHNA Pharmaceutical Conference

Origami: Not just for paper anymore

Thursday, April 28, 2011

CPhI innovation awards open for entries

CPhI innovation awards open for entries

Genta begins tesetaxel trial in Japan

Motor protein may offer promise in ovarian cancer treatment

Karo Bio and Alkem collaborate to develop eprotirome for dyslipidemia

Marina publishes data on application of DiLA2 delivery technology for systemic delivery of siRNAs

Tuesday, April 26, 2011

Joint Call for project proposals in the field of Nanomaterials Research

US FDA approves Menactra, a vaccine to prevent meningococcal disease in infants and toddlers

Venus Remedies completes phase I & II trials of cancer detection molecule, Tumatrek

Suven Life secures 7 product patents in key markets

Lupin signs patent license agreement with Abbott

Celsion receives Japanese patent covering ThermoDox technologies

Diabetic completes first-ever polar flight of its kind

Scientists Engineer Nanoscale Vaults to Encapsulate 'Nanodisks' for Drug Delivery

Attractive men have long ring fingers: Study

Sunday, April 24, 2011

Maharashtra to include Ayurveda as part of MBBS syllabus

NicOx withdraws MAA for its osteoarthritis candidate naproxcinod in Europe

Amgen, UCB phase 2 study of AMG 785/CDP7851 in patients with postmenopausal osteoporosis meets primary endpoint

CytRx increases clinical sites to 15 in tamibarotene phase II b trial in 1st line NSCLC to expedite patient recruitment

GW Pharma gets US patent for Sativex in cancer pain

Friday, April 22, 2011

Boehringer Ingelheim's lead hepatitis C compound moves into phase III

REACT study to evaluate impact of Daxas® (roflumilast) in patients receiving standard COPD treatment

Pfizer to Sell Capsugel to KKR

Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China

Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion

Thursday, April 21, 2011

Bangalore India Bio 2011’ focuses on biotech for improving quality of life, starts on May 4

Bangalore India Bio 2011’ focuses on biotech for improving quality of life, starts on May 4

Mylan launches generic version of Famvir tablets

Phase III data shows NVA237 significantly improves lung function with good safety profile in COPD patients

Amira Pharma's lead LPA1 antagonist AM152 to treat idiopathic pulmonary fibrosis gets US FDA orphan drug status

NIH scientists identify gene that could hold the key to muscle repair

Malvern’s Zetasizer Nano proves to be the perfect instrument for a student environment

Importance of UID (Unique Identification Code) for pharma products

FDCA introduces online pharmacy registration

Uloric is First New Gout Drug in More Than 40 Years


Wednesday, April 20, 2011

Solid lipid nanoparticles: A drug carrier system

World Drug Delivery Congress 2011


Dr L H Hiranandani Hospital in collaboration with International Oncology Centre opens cancer centre in Mumbai

Health ministry sets up task force to develop software for drug mfg & tracking system

Lupin gets USFDA nod for metformin hydrochloride extended-release tablets 500mg & 1000mg

Keryx's Japanese partner begins phase 3 programme of ferric citrate to treat patients with hyperphosphatemia

Tuesday, April 19, 2011

US FDA seeks additional clinical data from Lilly's liprotamase NDA to treat exocrine pancreatic insufficiency

ICMR to begin research on antimicrobial resistance

Amarin's AMR101 phase III anchor trial meets all primary and secondary endpoints

TRTB to launch blue diamond pill targeting ethnic market with sexual enhancement pills

NIH researchers complete whole-exome sequencing of skin cancer

Monday, April 18, 2011

MSD India launches pentavalent rotavirus vaccine in India

GSK submits additional information to US FDA for candidate meningococcal and Hib combination vaccine

Axcan to acquire Mpex Pharmaceuticals

US FDA approves Actemra to treat systemic juvenile idiopathic arthritis

Sunday, April 17, 2011

NIH researchers identify cause and new treatment for common recurrent fever in children

NIH scientists identify gene that could hold the key to muscle repair

Astex commences phase I study for AZD5363 in anti-cancer collaboration with AstraZeneca

India among top countries witnessing high incidence of stillbirths

RegeneRx focuses immediate clinical development on dry eye indication with RGN-259

Saturday, April 16, 2011

FDA approves new medical device for form of brain cancer

Friday, April 15, 2011

Researchers Make First Bioartificial Organ In Spain

First Patient Enrolled In Isofol Medical's Initial Trial With Modufolin(R) For Treatment Of Neoadjuvant Rectal Cancer

Astex commences phase I study for AZD5363 in anti-cancer collaboration with AstraZeneca

Liposomal drug delivery systems

Thursday, April 14, 2011

Pfizer to support immatics' pivotal phase III study with IMA901, a therapeutic vaccine for advanced RCC patients

Watson files Moxifloxacin ANDA with US FDA

Novartis discontinues phase III trial of Tasigna

Marinus Pharma receives US patent for ganaxolone

Lpath initiates enrolment of iSONEP phase I b/II a proof-of-concept trial

Kinaxo Biotechnologies gets European patent for chemical proteomics applications

Apeptico initiates phase I trial with AP301 in pulmonary oedema

Phase II/III trial of S. aureus vaccine V710 fails, DMC recommends suspension of enrolment

US FDA approves test for bacteria that can cause serious intestinal disease

Tafamidis, an oral, investigational compound to treat TTR-FAP sustained a slowing of disease progression over 30 months

Tuesday, April 12, 2011

Evidence Lacking for Efficacy of Memantine in Treating Mild Alzheimer Disease

Promising Pre-Clinical Results for Oral Delivery of the Anti-Cancer Drug Docetaxel Using a Novel Nanotechnology Approach

Monday, April 11, 2011

New potential drug targets discovered for preventing prostate cancer cell growth

Sunday, April 10, 2011

Studies find possible new genetic risk factors for Alzheimer's disease

Bypass surgery, medications both options to be considered for heart failure patients with coronary artery disease

Saturday, April 9, 2011

The darker side of nanotechnology: nanotoxicology

Thursday, April 7, 2011

Alternate Method Of Prostate Cancer Diagnosis

Why Breast Cancer Is So Poorly Managed In Developing Countries

New Type Of Polymers Seek Out And Destroy MRSA Superbug And Leave Healthy Cells Alone

FDA Approves New Device To Treat Brain Aneurysms